Advertisement

Lexeo Therapeutics, Inc. LXEO

Set alert

Price alert · LXEO

All alert types
3.14 USD +0.08 +2.61%

At close · Oct 30

3.14 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
3.13 × 2
Ask
3.14 × 2
2.90 Day range 3.30
2.63 52-week range 10.63
YTD
-68.38%
1 year
-66.70%
Open
3.10
Prev close
3.06
Mkt cap
257.76M
Vol
1.00M
Avg vol
1.30M
EPS
-1.02
P/E
0.00
Div yield
0.00%
More statistics
Low
2.90
High
3.30
Forward P/E
-2.24
Beta
0.00
Short ratio
6.55
Inst. own
91.48%
Dividend
0.00
Ex-div date
Earnings
May 9, 2024
50-d avg
7.92
200-d avg
11.86
1y target
22.29

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for LXEO has not been loaded yet. Try again in a moment.

Revenue & Expenses

Other Income → Expenses: $456.00KExpenses → Selling, General & Admin: $2.65MExpenses → Research & Development: $15.36MExpenses → Interest Expense: $29.00KGross Profit → Expenses: $531.00KRevenue → Gross Profit: $531.00KNet Loss → Expenses: $17.05MOther Income$456.00KGross Profit$531.00KNet Loss$17.05MExpenses$18.04MSelling, General & Admin$2.65MResearch & Development$15.36MInterest Expense$29.00KRevenue$531.00K

Period ending Jun 30, 2026 · select a line to chart its history

Income statement

LXEO quarterly income statement
28.02M
19.03M
8.99M
-28.02M
14.00K
-25.87M
-25.87M
-25.87M
-25.87M
-0.30
-0.30
-0.30
-25.85M
-25.85M
85.63M
85.63M

Balance sheet

LXEO quarterly balance sheet
96.08M
96.08M
144.73M
118.87M
25.86M
217.91M
7.88M
254.90M
2.67M
6.81M
15.69M
4.14M
19.84M
-426.20M
-298.00K
235.06M
235.06M
36.99M
6.81M
4.14M
4.18M

Cash flow

LXEO quarterly cash flow
556.00K
24.40M
21.07M
-7.00K
25.34M
-142.00K
14.26M
14.27M
-17.60M
5.69M
Advertisement